NADLA SOARES CASSEMIRO

Dr. NADLA SOARES CASSEMIRO

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
IEIsabelly Teixeira Espinoça
Isabelly Teixeira Espinoça
DBDenise Caroline Luiz Soares Basilio
Denise Caroline Luiz Soares Basilio
AAAnna Júlia Papa de Araujo
Anna Júlia Papa de Araujo
RORafael Seiji Nakano Ota
Rafael Seiji Nakano Ota
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
EPEduardo Benedetti Parisotto
Eduardo Benedetti Parisotto
The study aimed to evaluate the antithrombotic action of Acrocomia aculeata pulp oil (AAPO) in natura, in an in vitro experimental model. AAPO was obtained by solvent extraction, and its chemical characterization was performed by gas chromatography coupled to a mass spectrometer (GC-MS). In vitro toxicity was evaluated with the Trypan Blue exclusion test and in vivo by the Galleria mellonella model. ADP/epinephrine-induced platelet aggregation after treatment with AAPO (50, 100, 200, 400, and 800 μg/mL) was evaluated by turbidimetry, and coagulation was determined by prothrombin activity time (PT) and activated partial thromboplastin time (aPTT). Platelet activation was measured by expression of P-selectin on the platelet surface by flow cytometry and intraplatelet content of reactive oxygen species (ROS) by fluorimetry. The results showed that AAPO has as major components such as oleic acid, palmitic acid, lauric acid, caprylic acid, and squalene. AAPO showed no toxicity in vitro or in vivo. Platelet aggregation decreased against agonists using treatment with different concentrations of AAPO. Oil did not interfere in PT and aPTT. Moreover, it expressively decreased ROS-induced platelet activation and P-selectin expression. Therefore, AAPO showed antiplatelet action since it decreased platelet activation verified by the decrease in P-selectin expression as well as in ROS production.

27 September 2021 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
NCNADLA SOARES CASSEMIRO
NADLA SOARES CASSEMIRO
LSLuana Bonifácio Sanches
Luana Bonifácio Sanches
NKNatalia Naomi Kato
Natalia Naomi Kato
RRRoberto Ruller
Roberto Ruller
CCCarlos Alexandre Carollo
Carlos Alexandre Carollo
DSDenise B Silva
Denise B Silva

8 March 2021 in Life
Verified
Journal Article
Open access
PDF file
BLBethania Lorencone
Bethania Lorencone
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Background: Costus spicatus (Jacq.) Sw. is a medicinal species frequently prescribed for the treatment of cardiovascular diseases. This study aims to evaluate the effects of this species against the development of atherosclerosis. Methods: First, an anatomical study of the C. spicatus leaves was performed. Then, the extract (ESCS) was obtained and submitted to phytochemical analysis. Female rats were treated with a single dose of ESCS (2000 mg/kg) to assess acute toxicity. Other groups of female rats received an atherogenic diet for 60 days. After 30 days, the animals were treated orally with ESCS (30 and 300 mg/kg), rosuvastatin (5 mg/kg), or vehicle once daily for 30 days. Serum lipids oxidized low-density lipoprotein, soluble adhesion molecules, interleukins 1β and 6, and markers of renal and liver function were measured. Renal function, blood pressure, electrocardiography, and vascular reactivity were also evaluated. Arteries, heart, liver, and kidney were also collected to evaluate the tissue redox state and histopathological analysis. Results: Prolonged treatment with ESCS induces significant hypolipidemic and antioxidant effects, that prevent endothelial dysfunction and modulated the local inflammatory process, reducing the evolution of the atherosclerotic disease. Conclusions: This study provides a scientific basis for the popular use of C. spicatus for the treatment of atherosclerosis.

25 November 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Paola dos Santos da RochaPaola dos Santos da Rocha
Paola dos Santos da Rocha
Sarah Lam OruéSarah Lam Orué
Sarah Lam Orué
DLDaniel Ferreira Leite
Daniel Ferreira Leite
PEPriscilla Pereira de Toledo Espindola
Priscilla Pereira de Toledo Espindola
NCNADLA SOARES CASSEMIRO
NADLA SOARES CASSEMIRO
KSKely De Picoli Souza
Kely De Picoli Souza
Obesity is an epidemic disease worldwide, associated with oxidative stress and the development of several other diseases. Bauhinia rufa (Bong.) Steud. is a native Brazilian Cerrado medicinal plant popularly used for the treatment of obesity. In this context, we investigated the chemical composition of the methanolic extract of B. rufa leaves (MEBr) and evaluated the antioxidant activity and its impact on the prevention and treatment of obesity in mice fed a high‐fat diet (HFD 60%). Additionally, the acute oral toxicity of MEBr was evaluated. In MEBr, 17 glycosylated compounds were identified, including myricetin, quercetin, kaempferol, coumaroyl, cyanoglucoside, and megastigmane. In vitro, MEBr showed antioxidant activity in different methods: DPPH•, ABTS•+, FRAP, iron‐reducing power, inhibition of β‐carotene bleaching, and inhibition of DNA fragmentation. In human erythrocytes, MEBr increased the activities of antioxidant enzymes, superoxide dismutase, and catalase. Under oxidative stress, MEBr reduced oxidative hemolysis, and the malondialdehyde (MDA) levels generated in erythrocytes. Mice treated acutely with MEBr (2000 mg/kg) showed no signs of toxicity. During 90 days, the mice received water or MEBr simultaneously with HFD for induction of obesity. At this stage, MEBr was able to reduce the gain of subcutaneous white adipose tissue (WAT) and prevent the increase of MDA in the heart and brain. After 180 days of HFD for obesity induction, mice that received MEBr simultaneously with HFD (HFD‐MEBr) in the last 60 days of treatment (120‐180 days) showed a reduction of retroperitoneal and mesenteric WAT deposits and MDA levels in the heart, liver, kidney, and brain, compared to the HFD‐Control group. These effects of MEBr were similar to mice treated with sibutramine (HFD‐Sibutramine, 2 mg/kg). Combined, the results show that compounds from the leaves of B. rufa affect controlling oxidative stress and actions in the prevention and treatment of obesity. Thus, associated oxidative stress reduction and body composition modulation, in obese people, can contribute to the prevention of obesity‐related comorbidities and improve quality of life.

14 July 2021 in Planta Medica International Open
Verified
Journal Article
Open access
PDF file
DBDaniela Z. de Brito
Daniela Z. de Brito
NCNADLA SOARES CASSEMIRO
NADLA SOARES CASSEMIRO
JSJeana M. E. de Souza
Jeana M. E. de Souza
GDGeraldo A. Damasceno-Junior
Geraldo A. Damasceno-Junior
RORodrigo J. Oliveira
Rodrigo J. Oliveira
MCMarilene Rodrigues Chang
Marilene Rodrigues Chang
The Pantanal wetland harbors a rich flora with uncharted pharmacological potential. This study evaluated 20 Brazilian Pantanal plants against Candida albicans, C. parapsilosis, C. tropicalis, and C. krusei. Fungal susceptibility was determined by agar diffusion and broth microdilution; active compounds were identified by bioautography and HPLC-DAD-MS/MS. Sesbania virgata, Polygala molluginifolia, and Cantinoa mutabilis extracts and their chloroform and ethyl acetate (EtOAc) fractions exhibited the best activity against all Candida species tested. The EtOAc fraction of P. molluginifolia proved to be more efficient in inhibiting C. parapsilosis and C. krusei growth (Minimum inhibitory concentration of 125 and 62.5 μg/mL, respectively). Bioautography of this fraction revealed two active bands, characterized by HPLC-DAD-MS/MS as a mixture of podophyllotoxin derivatives blumenol, besides some flavonoids. This work demonstrated antifungal potential of P. molluginifolia podophyllotoxin derivatives and the versatility of bioautography with HPLC-DAD-MS/MS to identify the bioactive compounds. # Daniela Z. de Brito and Nadla S. Cassemiro have equally contributed to the work and are co-authors. Received: 04 December 2020 Received: 20 April 2021 Accepted: 27 April 2021 Publication Date: 14 July 2021 (online) © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

30 June 2025 in Plants
Verified
Journal Article
Open access
PDF file
KRKátia Ribeiro
Kátia Ribeiro
RSRúbia Bellard e Silva
Rúbia Bellard e Silva
JRJoão Paulo Costa Rodrigues
João Paulo Costa Rodrigues
Mairon César CoimbraMairon César Coimbra
Mairon César Coimbra
LPLaura Jéssica Pereira
Laura Jéssica Pereira
RCRenê Couto
Renê Couto
Celtis iguanaea, widely used in Brazilian folk medicine, is known for its analgesic and anti-inflammatory properties. This study evaluated the in vitro antioxidant capacity and the in vivo antinociceptive and anti-inflammatory mechanisms of the standardized spray-dried Celtis iguanaea hydroethanolic leaf extract (SDCi). Phytochemical analysis showed that SDCi contains 21.78 ± 0.82 mg/g polyphenols, 49.69 ± 0.57 mg/g flavonoids, and 518.81 ± 18.02 mg/g phytosterols. UFLC-DAD-MS identified iridoid glycosides, p-coumaric acid glycosides, flavones, and unsaturated fatty acids. Antioxidant assays revealed an IC50 of 301.6 ± 38.8 µg/mL for DPPH scavenging and an electrochemical index of 6.1 μA/V. In vivo, SDCi (100–1000 mg/kg, p.o) did not impair locomotor function (rotarod test) but significantly reduced acetic acid-induced abdominal writhing and both phases of the formalin test at higher doses (300 and 1000 mg/kg). The antinociceptive effects were independent of α-2 adrenergic receptors. SDCi also increased latency in the hot-plate test and reduced paw edema in the carrageenan model, accompanied by decreased IL-1β and increased IL-10 levels. Histological analysis showed a 50% reduction in inflammatory cell infiltration. These findings support SDCi as an effective anti-inflammatory and antinociceptive phytopharmaceutical intermediate, with potential applications in managing pain and inflammation.